Related Experiment Video
Updated: Jan 5, 2026
03:19
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
Published on: June 21, 2024
2.0K
Introduction to the special issue: "Focus on pediatric nephrology"
, R Chimenz1
1Chief UOSD Pediatric Nephrology, AOUP Policlinico G. Martino, Messina.
Journal of Biological Regulators and Homeostatic Agents
|October 22, 2019
Summary
This review covers pediatric nephro-urological conditions, including glomerular and urologic diseases, and their management. It highlights the need for specialized pediatric dialysis and explores novel treatments like ozone therapy.
Area of Science:
- Pediatric Nephrology and Urology
- Renal Medicine
- Clinical Case Studies
Background:
- Focuses on nephro-urological abnormalities in children, encompassing glomerular diseases (nephrotic syndrome, Alport syndrome, chronic glomerulonephritis) and urologic conditions (multicystic dysplastic kidney, obstructive pathologies, stones).
- Addresses congenital syndromes (VACTERL, Fabry, Goldenhar) and acquired conditions (Schoenlein-Henoch disease) impacting renal health.
- Explores the role of oxidative stress in neonatal renal failure progression, particularly when combined with congenital renal anomalies.
Discussion:
- Compares adult and pediatric dialysis, detailing specific physical and staffing requirements for children.
- Presents a clinical case of a child undergoing dialysis, treated with innovative topical ozone therapy for infantile atopic dermatitis.
- Discusses the necessity of dialysis for pediatric patients with kidney failure, especially those with congenital renal anomalies.
Key Insights:
- Pediatric kidney diseases require specialized diagnostic and therapeutic approaches.
- Oxidative stress is a significant factor in neonatal renal failure.
- Pediatric dialysis presents unique challenges compared to adult dialysis.
- Topical ozone therapy shows potential as an adjunctive treatment in pediatric dermatology for patients with kidney issues.
Outlook:
- Further research into novel therapeutic strategies for pediatric kidney diseases is warranted.
- Continued investigation into the role of oxidative stress in neonatal kidney health is crucial.
- Development of specialized protocols for pediatric dialysis can improve patient outcomes.
- Exploration of innovative treatments like ozone therapy for associated conditions in pediatric nephrology patients should be pursued.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
184
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
184
01:25Chronic Kidney Disease I: Introduction
529
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
529
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
163
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
163
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
210
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
227
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
227
01:20Acute Kidney Injury V: Interprofessional Care
258
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
258